RESEARCH
PUBLICATIONS
NEXTBIO COMMUNITY
-
Toxin B is essential for virulence of Clostridium difficile.
Authors: Dena Lyras, Jennifer R O'Connor, Pauline M Howarth, Susan P Sambol, Glen P Carter, Tongted Phumoonna, Rachael Poon, Vicki Adams, Gayatri Vedantam, Stuart Johnson,…
Nature 2009 Apr 30 -
Autocatalytic cleavage of Clostridium difficile toxin B.
Authors: Jessica Reineke, Stefan Tenzer, Maja Rupnik, Andreas Koschinski, Oliver Hasselmayer, André Schrattenholz, Hansjörg Schild, Christoph von Eichel-Streiber
Nature 2007 Mar 22
Thought leaders and organizations working on research involving clostridium difficile.
- L Clifford McDonald
- J Scott Weese
- Neil F Fairweather
- Dale N Gerding
- Alexander Rodriguez-Palacios
- VA Medical Center, Houston
- Genzyme
- Sanofi-Aventis
- University of Pittsburgh
- Hadassah Medical Organization
- Beth Israel Deaconess Medical Center
- University of Guelph
- Imperial College London
- Wellcome Trust Sanger Institute
- Washington University School of Medicine
-
Use of Recombinant Human Lactoferrin in Long-Term Care Patients With Feeding Tubes With Clostridium Difficile.
conditions: Clostridium Difficile
interventions: recombinant human lactoferrin
-
Study of Nitazoxanide in the Treatment of Clostridium Difficile Colitis
conditions: Clostridium Difficile
interventions: Nitazoxanide ; Metronidazole
-
Clostridium Difficile Investigation
Associated Content. - January 25, 2010 -
What Is Clostridium Difficile (C. Difficile)?
Medical News Today. - November 26, 2009
Community
-
No NextBio users were found for “clostridium difficile”.
Complete your user profile with your interests, if you want others to find you within the NextBio community.
-
No NextBio groups were found for “clostridium difficile”.
Be the first to start a group and share your interests with others within the NextBio community.
